The Comirnaty 2025-2026 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, a descendant of JN.1. The Food and Drug Administration (FDA) has approved Comirnaty ® (LP.8.1-adapted monovalent ...
Yes, it's true Comirnaty is already available, but Georgia may not receive doses of the branded vaccine until mid-October. "During clinical trials and emergency use authorization, vaccines typically ...
On Aug. 23, the Pfizer-BioNTech vaccine became the first COVID-19 vaccine to receive full approval from the U.S. Food and Drug Administration (FDA). Before approval was granted, the Pfizer vaccine had ...
• Spikevax and Comirnaty are brand names for the Moderna and Pfizer COVID-19 vaccines, respectively. The drug formulation is the same for the branded and non-branded vaccines. • The non-branded ...
The FDA approval is based on the cumulative body of evidence supporting the safety and efficacy of the Pfizer-BioNTech COVID-19 vaccine, including clinical trial data supporting the approval for ...
The FDA allows people 12 to 15 years of age to get the Pfizer-BioNTech vaccine under Emergency Use Authorization (EUA). “The FDA-approved COMIRNATY® (COVID-19 Vaccine, mRNA) and the EUA-authorized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback